Dr. Vahid Tabibzadeh is a Los Angeles, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 10833 Le Conte Ave, Room 53-076 Chs, Los Angeles. Patients can reach him at 310-825-3685.
Dr. Vahid Tabibzadeh deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Vahid Tabibzadeh speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Vahid Tabibzadeh
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S., M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
10833 Le Conte Ave, Room 53-076 Chs, Los Angeles, California, 90095-1668
Phone:
310-825-3685
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
2961787676
Enrollment ID:
I20170321000518
NPI Number:
1760796726
NPI Enumeration Date:
02 Aug, 2010
NPI Last Update On:
02 Aug, 2010
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10833 Le Conte Ave, Room 53-076 Chs Los Angeles, California
Zip:
90095-1668
Phone Number:
310-825-3685
Patients can reach Dr. Vahid Tabibzadeh at 10833 Le Conte Ave, Room 53-076 Chs, Los Angeles, California or can call to book an appointment on 310-825-3685. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.